Cysteine depletion induces pancreatic tumor ferroptosis in mice.

Cysteine depletion induces pancreatic tumor ferroptosis in mice.
复制标题

DOI:
10.1126/science.aaw9872
复制
发表时间:
2020-04-03
期刊:
Science (New York, N.Y.)
影响因子:
--
通讯作者:
Olive KP
Olive KP
中科院分区:
其他
文献类型:
--
作者:
Badgley MA;Kremer DM;Maurer HC;DelGiorno KE;Lee HJ;Purohit V;Sagalovskiy IR;Ma A;Kapilian J;Firl CEM;Decker AR;Sastra SA;Palermo CF;Andrade LR;Sajjakulnukit P;Zhang L;Tolstyka ZP;Hirschhorn T;Lamb C;Liu T;Gu W;Seeley ES;Stone E;Georgiou G;Manor U;Iuga A;Wahl GM;Stockwell BR;Lyssiotis CA;Olive KP

文献摘要

参考文献

被引文献

相似文献

铁凋亡是由脂质活性氧(ROS)的灾难性积累引起的细胞死亡的一种形式。致癌信号在许多肿瘤类型中升高脂质ROS的产生,并且被来自氨基酸半胱氨酸的代谢物抵消。在这里,我们表明,通过系统xC-氧化半胱氨酸(胱氨酸)的进口是胰腺导管腺癌(PDAC),癌症死亡率的主要原因的关键依赖。利用半胱氨酸合成谷胱甘肽和辅酶A,二者结合控制铁凋亡。研究基因工程小鼠,我们发现缺失系统xC-亚基Slc 7a 11可诱导肿瘤选择性铁凋亡并抑制PDAC生长。这是通过给予半胱氨酸酶(一种消耗半胱氨酸/胱氨酸的药物)复制的,证明了诱导PDAC中铁凋亡的可转化方法。胱氨酸输入的遗传和药理学靶向诱导基因工程小鼠胰腺肿瘤中的癌症选择性铁凋亡。
Ferroptosis is a form of cell death resulting from the catastrophic accumulation of lipid reactive oxygen species (ROS). Oncogenic signaling elevates lipid ROS production in many tumor types and is counteracted by metabolites derived from the amino acid cysteine. Here we show that the import of oxidized cysteine (cystine) via system xC– is a critical dependency of pancreatic ductal adenocarcinoma (PDAC), a leading cause of cancer mortality. Cysteine was used to synthesize glutathione and coenzyme A which combined to control ferroptosis. Studying genetically engineered mice, we found that deletion of a system xC– subunit, Slc7a11, induced tumor-selective ferroptosis and inhibited PDAC growth. This was replicated through administration of cyst(e)inase, a drug that depletes cysteine/cystine, demonstrating a translatable means to induce ferroptosis in PDAC. Genetic and pharmacological targeting of cystine import induces cancer-selective ferroptosis in pancreatic tumors of genetically engineered mice.
DOI: 10.1016/j.cell.2012.03.042
发表时间: 2012-05-25
期刊: Cell
影响因子: 64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者: Stockwell BR
DOI: 10.1093/nar/gkv007
发表时间: 2015-04-20
影响因子: 14.9
作者:
Ritchie ME;Phipson B;Wu D;Hu Y;Law CW;Shi W;Smyth GK
通讯作者: Smyth GK
DOI: 10.1038/nm.4232
发表时间: 2017-01
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1158/1078-0432.ccr-18-3281
发表时间: 2019-09-01
影响因子: 11.5
作者:
Eberle-Singh, Jaime A.;Sagalovskiy, Irina;Olive, Kenneth P.
通讯作者: Olive, Kenneth P.
DOI: 10.1038/ncb3064
发表时间: 2014-12
影响因子: 21.3
作者:
Friedmann Angeli JP;Schneider M;Proneth B;Tyurina YY;Tyurin VA;Hammond VJ;Herbach N;Aichler M;Walch A;Eggenhofer E;Basavarajappa D;Rådmark O;Kobayashi S;Seibt T;Beck H;Neff F;Esposito I;Wanke R;Förster H;Yefremova O;Heinrichmeyer M;Bornkamm GW;Geissler EK;Thomas SB;Stockwell BR;O'Donnell VB;Kagan VE;Schick JA;Conrad M
通讯作者: Conrad M